Rifaximin for Functional Dyspepsia
NCT01643083
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
95
Enrollment
OTHER
Sponsor class
Conditions
Functional Dyspepsia
Interventions
DRUG:
Rifaximin
DRUG:
Placebo
Sponsor
The University of Hong Kong